124 related articles for article (PubMed ID: 10360757)
1. The structure-based design and synthesis of selective inhibitors of Trypanosoma cruzi dihydrofolate reductase.
Zuccotto F; Brun R; Gonzalez Pacanowska D; Ruiz Perez LM; Gilbert IH
Bioorg Med Chem Lett; 1999 May; 9(10):1463-8. PubMed ID: 10360757
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase.
Schormann N; Velu SE; Murugesan S; Senkovich O; Walker K; Chenna BC; Shinkre B; Desai A; Chattopadhyay D
Bioorg Med Chem; 2010 Jun; 18(11):4056-66. PubMed ID: 20452776
[TBL] [Abstract][Full Text] [Related]
3. Novel inhibitors of Trypanosoma cruzi dihydrofolate reductase.
Zuccotto F; Zvelebil M; Brun R; Chowdhury SF; Di Lucrezia R; Leal I; Maes L; Ruiz-Perez LM; Gonzalez Pacanowska D; Gilbert IH
Eur J Med Chem; 2001 May; 36(5):395-405. PubMed ID: 11451529
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and testing of 5-benzyl-2,4-diaminopyrimidines as potential inhibitors of leishmanial and trypanosomal dihydrofolate reductase.
Chowdhury SF; Guerrero RH; Brun R; Ruiz-Perez LM; Pacanowska DG; Gilbert IH
J Enzyme Inhib Med Chem; 2002 Oct; 17(5):293-302. PubMed ID: 12683746
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase.
Khabnadideh S; Pez D; Musso A; Brun R; Pérez LM; González-Pacanowska D; Gilbert IH
Bioorg Med Chem; 2005 Apr; 13(7):2637-49. PubMed ID: 15755663
[TBL] [Abstract][Full Text] [Related]
6. 2,4-Diaminopyrimidines as inhibitors of Leishmanial and Trypanosomal dihydrofolate reductase.
Pez D; Leal I; Zuccotto F; Boussard C; Brun R; Croft SL; Yardley V; Ruiz Perez LM; Gonzalez Pacanowska D; Gilbert IH
Bioorg Med Chem; 2003 Nov; 11(22):4693-711. PubMed ID: 14556785
[TBL] [Abstract][Full Text] [Related]
7. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and evaluation of inhibitors of trypanosomal and leishmanial dihydrofolate reductase.
Chowdhury SF; Villamor VB; Guerrero RH; Leal I; Brun R; Croft SL; Goodman JM; Maes L; Ruiz-Perez LM; Pacanowska DG; Gilbert IH
J Med Chem; 1999 Oct; 42(21):4300-12. PubMed ID: 10543874
[TBL] [Abstract][Full Text] [Related]
9. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
Senkovich O; Schormann N; Chattopadhyay D
Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
[TBL] [Abstract][Full Text] [Related]
10. Dihydrofolate reductase: a potential drug target in trypanosomes and leishmania.
Zuccotto F; Martin AC; Laskowski RA; Thornton JM; Gilbert IH
J Comput Aided Mol Des; 1998 May; 12(3):241-57. PubMed ID: 9749368
[TBL] [Abstract][Full Text] [Related]
11. Novel inhibitors of Leishmanial dihydrofolate reductase.
Chowdhury SF; Di Lucrezia R; Guerrero RH; Brun R; Goodman J; Ruiz-Perez LM; Pacanowska DG; Gilbert IH
Bioorg Med Chem Lett; 2001 Apr; 11(8):977-80. PubMed ID: 11327604
[TBL] [Abstract][Full Text] [Related]
12. Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development.
Cavazzuti A; Paglietti G; Hunter WN; Gamarro F; Piras S; Loriga M; Allecca S; Corona P; McLuskey K; Tulloch L; Gibellini F; Ferrari S; Costi MP
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1448-53. PubMed ID: 18245389
[TBL] [Abstract][Full Text] [Related]
13. Interactions of 5-deazapteridine derivatives with Mycobacterium tuberculosis and with human dihydrofolate reductases.
da Cunha EF; de Castro Ramalho T; Bicca de Alencastro R; Maia ER
J Biomol Struct Dyn; 2004 Oct; 22(2):119-30. PubMed ID: 15317473
[TBL] [Abstract][Full Text] [Related]
14. A substructure approach toward polymeric receptors targeting dihydrofolate reductase inhibitors. 2. Molecularly imprinted polymers against Z-l-glutamic acid showing affinity for larger molecules.
Hall AJ; Achilli L; Manesiotis P; Quaglia M; De Lorenzi E; Sellergren B
J Org Chem; 2003 Nov; 68(23):9132-5. PubMed ID: 14604396
[TBL] [Abstract][Full Text] [Related]
15. Novel 8-deaza-5,6,7,8-tetrahydroaminopterin derivatives as dihydrofolate inhibitor: design, synthesis and antifolate activity.
Zhang Z; Wu J; Ran F; Guo Y; Tian R; Zhou S; Wang X; Liu Z; Zhang L; Cui J; Liu J
Eur J Med Chem; 2009 Feb; 44(2):764-71. PubMed ID: 18555562
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of guanylthiourea derivatives as potential inhibitors of Plasmodium falciparum dihydrofolate reductase enzyme.
Adane L; Bhagat S; Arfeen M; Bhatia S; Sirawaraporn R; Sirawaraporn W; Chakraborti AK; Bharatam PV
Bioorg Med Chem Lett; 2014 Jan; 24(2):613-7. PubMed ID: 24361001
[TBL] [Abstract][Full Text] [Related]
17. Comparative mapping of on-targets and off-targets for the discovery of anti-trypanosomatid folate pathway inhibitors.
Panecka-Hofman J; Pöhner I; Spyrakis F; Zeppelin T; Di Pisa F; Dello Iacono L; Bonucci A; Quotadamo A; Venturelli A; Mangani S; Costi MP; Wade RC
Biochim Biophys Acta Gen Subj; 2017 Dec; 1861(12):3215-3230. PubMed ID: 28939533
[TBL] [Abstract][Full Text] [Related]
18. Lipophilic conjugates of methotrexate with short-chain alkylamino acids as DHFR inhibitors. Synthesis, biological evaluation, and molecular modeling.
Pignatello R; Guccione S; Forte S; Di Giacomo C; Sorrenti V; Vicari L; Uccello Barretta G; Balzano F; Puglisi G
Bioorg Med Chem; 2004 Jun; 12(11):2951-64. PubMed ID: 15142554
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, dihydrofolate reductase inhibition, anti-proliferative testing, and saturation transfer difference ¹H-NMR study of some new 2-substituted-4,6-diaminopyrimidine derivatives.
Mohebbi S; Falcón-Pérez JM; González E; Millet O; Mato JM; Kobarfard F
Chem Pharm Bull (Tokyo); 2012; 60(1):70-8. PubMed ID: 22223377
[TBL] [Abstract][Full Text] [Related]
20. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
Ng HL; Chen S; Chew EH; Chui WK
Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
